Home » Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem
Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem
Jazz Pharmaceuticals announced a new patent related to Xyrem (sodium oxybate) oral solution titled “Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy” was issued. The new patent, number 8,262,650, will be submitted for listing in the FDA’s Orange Book.
The Sacramento Bee
The Sacramento Bee
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May